58-17b-502.   Unprofessional conduct.
"Unprofessional conduct" includes:
(1)  willfully deceiving or attempting to deceive the division, the board, or
their agents as to any relevant matter regarding compliance under this
chapter;
(2) (a)  except as provided in Subsection (2)(b):
(i)  paying or offering rebates to practitioners or any other health care
providers, or receiving or soliciting rebates from practitioners or any other
health care provider; or
(ii)  paying, offering, receiving, or soliciting compensation in the form of a
commission, bonus, rebate, kickback, or split fee arrangement with
practitioners or any other health care provider, for the purpose of obtaining
referrals.
(b)  Subsection (2)(a) does not apply to:
(i)  giving or receiving price discounts based on purchase volume;
(ii)  passing along pharmaceutical manufacturer's rebates; or
(iii)  providing compensation for services to a veterinarian.
(3)  misbranding or adulteration of any drug or device or the sale,
distribution, or dispensing of any outdated, misbranded, or adulterated drug
or device;
(4)  engaging in the sale or purchase of drugs or devices that are samples or
packages bearing the inscription "sample" or "not for resale" or similar words
or phrases;
(5)  except as provided in Section 58-17b-503, accepting back and
redistributing of any unused drug, or a part of it, after it has left the
premises of any pharmacy, unless the drug is in a unit pack, as defined in
Section 58-17b-503, or the manufacturer's sealed container, as defined in
rule;
(6)  an act in violation of this chapter committed by a person for any form of
compensation if the act is incidental to the person's professional activities,
including the activities of a pharmacist, pharmacy intern, or pharmacy
technician;
(7)  violating Federal Title II, P.L. 91, Controlled Substances Act, Title 58,
Chapter 37, Utah Controlled Substances Act, or rules or regulations adopted
under either act;
(8)  requiring or permitting pharmacy interns or technicians to engage in
activities outside the scope of practice for their respective license
classifications, as defined in this chapter and division rules made in
collaboration with the board, or beyond their scope of training and ability;
(9)  administering:
(a)  without appropriate training, as defined by rule;
(b)  without a physician's order, when one is required by law; and
(c)  in conflict with a practitioner's written guidelines or written protocol
for administering;
(10)  disclosing confidential patient information in violation of the
provisions of the Health Insurance Portability and Accountability Act of 1996
or other applicable law;
(11)  engaging in the practice of pharmacy without a licensed pharmacist
designated as the pharmacist-in-charge;
(12)  failing to report to the division any adverse action taken by another
licensing jurisdiction, government agency, law enforcement agency, or court
for conduct that in substance would be considered unprofessional conduct under
this section;
(13)  as a pharmacist or pharmacy intern, preparing a prescription drug for
sale to another pharmacist or pharmaceutical facility; and
(14)  as a pharmacist or pharmacy intern, preparing a prescription drug in a
dosage form which is regularly and commonly available from a manufacturer in
quantities and strengths prescribed by a practitioner.
